Interlab Immunofixation Test(s)
510(k) K033187
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK033187 | Date19 Nov 2003 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- CFF
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.5510
- Advisory Committee
- Immunology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 25 Sep 2026
The Immunofixation Test is an in vitro diagnostic device used for the qualitative separation and identification of abnormal immunoglobulins (IgG, IgM, IgA) and kappa and lambda light chains in human serum and concentrated urine. It incorporates the use of specific antisera to heavy and light chains to precipitate immunoglobulins following electrophoresis, providing a highly sensitive and specific method to detect and classify monoclonal immunoglobulins.
This test is supplied by Interlab S.R.L. and is intended for use in clinical laboratories. The device is a Class II medical device cleared by the FDA under 510(k) K033187, with product code CFF. It is designed for use with the G26 EASYFIX instrument, which allows for total primary tube automation of routine electrophoresis tests including serum immunofixation and urine proteins analysis.
Other devices from Interlab S.R.L.
Questions
AI-generated answers, 25 Sep 2026
What is the purpose of the Interlab Immunofixation Test?
The Immunofixation Test is an in vitro diagnostic device used for the qualitative separation and identification of abnormal immunoglobulins (IgG, IgM, IgA) and kappa and lambda light chains in human serum and concentrated urine.
How is the Immunofixation Test supplied and what equipment is required?
The test is supplied by Interlab S.R.L. and is designed for use with the G26 EASYFIX instrument, which allows for total primary tube automation of routine electrophoresis tests including serum immunofixation and urine proteins analysis.
What is the regulatory classification of the Immunofixation Test?
The device is a Class II medical device cleared by the FDA under 510(k) K033187, with product code CFF. It is intended for use in clinical laboratories and has been determined to be substantially equivalent.
What types of samples can be analyzed with the Immunofixation Test?
The test can analyze human serum and concentrated urine samples to detect and classify monoclonal immunoglobulins using specific antisera to heavy and light chains following electrophoresis.